Chronic myeloid leukemia (CML) is characterized by the presence of a constitutively active Abl kinase, which is the product of a chimeric BCR-ABL gene, caused by the genetic translocation known as the Philadelphia chromosome. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.